Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Prototipo de un dispositivo médico para mejorar la cicatrización de heridas crónicas

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOLV20161125001
Publicado:
04/01/2017
Caducidad:
04/01/2018
Resumen:
Un grupo de investigadores de una universidad letona especializado en investigación médica ha desarrollado el prototipo de un dispositivo médico para mejorar la cicatrización de heridas crónicas. La oferta se refiere a la producción de un biomaterial funcionalizado biodegradable basado en ácido hialurónico para cicatrización de heridas. Este dispositivo, que tiene una patente europea, puede aplicarse en pacientes hospitalizados, residencias de la tercera edad o pacientes discapacitados. El grupo de investigación busca investigadores con el fin de establecer acuerdos comerciales con asistencia técnica.

Details

Tittle:
Prototype for chronic wound healing enhancing medical device
Summary:
Group of researchers from a university in Latvia engaged in medical research have developed a prototype for chronic wound healing enhancing medical device. The present invention relates primarily to production of functionalized biodegradable, hyaluronic acid based biomaterial, aimed at skin wound healing. Researchers are looking for commercial agreement with technical assistance.
Description:
Chronic wounds or ulcers are a common pathology, which is mainly related to diabetes and venous insufficiency. Chronic wounds can require long-term medical care which results in long-term loss of work ability and heavy direct and indirect costs. Latvian researchers have tested biodegradable biomaterial using the unique characteristics of hyaluronic acid to modulate cell niche and to promote chronic wound healing. The scaffolds prepared are functionalized with natural immune-modulator. The specific offer includes safety and efficiency in vitro tests, including scratch test and exudates analysis from patients and in vivo evaluation in experimental wound models in laboratory animals. The medical device can be applied for patients in hospitals, old people´s homes or individually for handicapped patients or cot cases. The prototype holds an EU patent. The university is interested in commercial agreement with technical assistance.
Advantages and Innovations:
Use of natural immuno-modulator as an active ingredient in hyaluronic acid based biodegradable biomaterial is proposed. Tissue restorative properties are demonstrated in both acute wounds and diabetic wound models. The wounds are proven to heal up to 30% faster (usually it takes 12-13 months) and recur in 15% less cases. The prototype holds an EU patent.
Stage of Development:
Available for demonstration
IPs:
Patents granted

Partner sought

Type and Role of Partner Sought:
The product is targeted to the manufacturers or retailers of medical devices. The university is looking looking for commercial agreement with technical assistance.
The potential partner is to be expected to obtain the patent for the device. The technical assistance and training will be provided by the university.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
Latvian
Russian

Keywords

Technology Keywords:
06001002 Investigaciones clínicas, ensayos
06001008 Medicina medioambiental, medicina social, medicina deportiva
06001013 Tecnología médica / ingeniería biomédica